Treatment for hemoptysis after percutaneous closure of a large intralobar pulmonary sequestration in elderly patient

Autor: Jian-Ming, Wang, Qi-Guang, Wang, Duan-Zhen, Zhang, Xian-Yang, Zhu

Publikováno v: Journal of Geriatric Cardiology : JGC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a8df03589135a84688232042a2434486
https://pubmed.ncbi.nlm.nih.gov/33117424

Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K/Akt and JNK signaling pathways

Autor: Qi Lv, Yufeng Xia, Zhifeng Wei, Xian-Yang Zhu, Yue Dai

Publikováno v: Chinese Journal of Natural Medicines. 13:831-841

Tetrandrine (Tet), the main active constituent of Stephania tetrandra root, has been demonstrated to alleviate adjuvant-induced arthritis in rats. The present study was designed to investigate the effects of Tet on the migration and invasion of rheum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1a6eb7410ca3de76bb983d7f9a6458
https://doi.org/10.1016/s1875-5364(15)30087-x

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1):results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Autor: András Temesvári, Sigita Aidietienė, Vladimir M. Shipulin, Jae Seung Lee, Pavel Jansa, Nuofu Zhang, Dominik Richard, Nguyen Vinh Pham, Carlos Jerjes Sanchez, Lan Hieu Nguyen, Keertan Dheda, Christian M. Kähler, Olga Barbarash, Piotr Podolec, Tomas Rene Pulido Zamudio, Michael M. Madani, Hyung Kwan Kim, Suree Sompradeekul, Grégoire Prévot, Silvia Ulrich, Luke Howard, Nattapong Jaimchariyatam, Olga Moiseeva, Gulfer Okumus, Zoheir Bshouty, Arintaya Phrommintikul, Friedrich Grimminger, David P. Jenkins, Heinrike Wilkens, Robin Condliffe, Irene Lang, John-David Aubert, Rudolf Speich, Tatiana Mularek-Kubzdela, Nicolas Martin, Hélène Bouvaist, Stephan Rosenkranz, Jun Bean Park, Peter F. Fedullo, Luke S. Howard, Olivier Sanchez, Gérald Simonneau, Ryszard Grzywna, Alexander Chernyavskiy, Zhi-Cheng Jing, Joanna Pepke-Zaba, Anton Vonk Noordegraaf, Andrea Maria D'Armini, Pablo Sepulveda Varela, Gang-Cheng Zhang, Nick H. Kim, Eckhard Mayer, Jerzy Lewczuk, Yuhong Mi, Zeynep Pinar Onen, Ekkehard Grünig, Xian-Yang Zhu, Marion Delcroix, John McConnell, Yuanhua Yang, Jin-Ming Liu, Lyubomyr Solovey, Kelly Papadakis, Xavier Jaïs, Istvan Edes, Tamila Vitalievna Martynyuk, Matthias Held, Kristóf Karlócai, Jarosław Kasprzak, Skaidrius Miliauskas, Hossein Ardeschir Ghofrani, Kim M. Kerr, Volodymyr Gavrysyuk

Publikováno v: Ghofrani, H A, Simonneau, G, D'Armini, A M, Fedullo, P, Howard, L S, Jaïs, X, Jenkins, D P, Jing, Z C, Madani, M M, Martin, N, Mayer, E, Papadakis, K, Richard, D, Kim, N H, Noordegraaf, A V & MERIT study investigators 2017, ' Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1) : results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study ', The Lancet Respiratory Medicine, vol. 5, no. 10, pp. 785-794 . https://doi.org/10.1016/S2213-2600(17)30305-3
The Lancet Respiratory Medicine, 5(10), 785-794. Elsevier Limited

Summary Background Macitentan is beneficial for long-term treatment of pulmonary arterial hypertension. The microvasculopathy of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension are similar. Methods The phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36794781d5eccbc59c72cb8cc5a212e5
https://research.vumc.nl/en/publications/4d05f687-13a9-445c-ba49-7129684838f4

The association between c.1333C > T genetic polymorphism ofMTHFRgene and the risk of congenital heart diseases

Autor: Jing Zhang, Bei Lv, Xia Li, Xian-yang Zhu, Qi-guang Wang

Publikováno v: Biomarkers. 19:77-80

This study aims to evaluate the influence of methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms on congenital heart diseases (CHD) risk. The frequencies of allelic and genotypic in CHD patients were significantly different from non-CHD co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b22348ab7e2e4ab6345771f7df821860
https://doi.org/10.3109/1354750x.2013.876099

Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension

Autor: Dong Bao Zhao, Da Xin Zhou, Jie Yan Shen, Xian Sheng Cheng, Zhi-Cheng Jing, Hua Yao, Xin Pan, Hong Gu, Xian Yang Zhu, Zhuoli Zhang, Yong Wang, Geoff Strange, Mei Xiang Xiang, Yue Jin Yang, Brad Dalton, Zhen Kun Yang

Publikováno v: The Journal of Heart and Lung Transplantation. 29:150-156

Bosentan has an established role in the management of pulmonary arterial hypertension (PAH). This clinical trial assessed the benefits of bosentan in the Chinese population.We investigated the efficacy and safety of bosentan in 92 Chinese citizens (m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590df6464d260c9dcaa9f890da0f5ce0
https://doi.org/10.1016/j.healun.2009.09.020